u/BrightLengthiness853 · 391d agono track record yet
$PCSA...low float biotech waking up ahead of a possible $450M+ licensing deal
Processa Pharmaceuticals is poised for a re-rating on a potential $452.5M licensing deal with Intact Therapeutics for its gastroparesis drug. The binding term sheet, combined with a tiny free float and recent unexplained volume spike, suggests early insider positioning ahead of an announcement that could unlock significant near-term cash and eliminate dilution concerns.
At post $9.00live price unavailable
1d+33.1%
3d+5.3%
1w+10.0%
1m-12.2%
3m-64.1%
6m-69.2%
1y-84.2%